These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 678104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
    McKhann CF, Hendrickson CG, Spitler LE, Gunnarsson A, Banerjee D, Nelson WR.
    Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intralesional immunotherapy of melanoma with BCG.
    Rosenberg SA, Rapp HJ.
    Med Clin North Am; 1976 May; 60(3):419-30. PubMed ID: 1271887
    [Abstract] [Full Text] [Related]

  • 5. Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG.
    Richman SP, Mavligit GM, Wolk R, Gutterman JU, Hersh EM.
    JAMA; 1975 Dec 22; 234(12):1233-5. PubMed ID: 1242748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fatal disseminated bacillus Calmette-Guerin infection and arrested growth of cutaneous malignant melanoma following intralesional immunotherapy.
    de la Monte SM, Hutchins GM.
    Am J Dermatopathol; 1986 Aug 22; 8(4):331-5. PubMed ID: 3532854
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intralesional immune therapy: methanol extraction residue of BCG or purified protein derivative.
    Lokich JJ, Garnick MB, Legg M.
    Oncology; 1979 Aug 22; 36(5):236-41. PubMed ID: 481845
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS, Mastrangelo MJ, Sulit H, Chee D, Yarbro JW, Prehn LM, Prehn RT.
    Natl Cancer Inst Monogr; 1973 Dec 22; 39():213-20. PubMed ID: 4595320
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).
    Henz BM, Macher E, Bröcker EB, Suciu S, Steerenberg PA, Jung E, Rümke P.
    Dermatology; 1996 Dec 22; 193(2):105-9. PubMed ID: 8884144
    [Abstract] [Full Text] [Related]

  • 18. Mycotic abdominal aortic aneurysm induced by immunotherapy with bacille Calmette-Guérin vaccine for malignancy.
    Woods JM, Schellack J, Stewart MT, Murray DR, Schwartzman SW.
    J Vasc Surg; 1988 Jun 22; 7(6):808-10. PubMed ID: 3286902
    [Abstract] [Full Text] [Related]

  • 19. Anaphylactic reaction to intralesional B.C.G.
    Proctor JW, Zidar B, Pomerantz M, Yamamura Y, Eng CP, Woodside D.
    Lancet; 1978 Jul 15; 2(8081):162. PubMed ID: 78369
    [No Abstract] [Full Text] [Related]

  • 20. Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma.
    Nathanson L, Schoenfeld D, Regelson W, Colsky J, Mittelman A.
    Cancer; 1979 May 15; 43(5):1630-5. PubMed ID: 376098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.